Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03703102
What this trial is testing

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kyowa Kirin, Inc. 274
Testing effectiveness (Phase 2)Study completedNCT04365387
What this trial is testing

Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Who this might be right for
Dermatitis, Atopic
Galderma R&D 242
Not applicableStudy completedNCT06353087
What this trial is testing

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Who this might be right for
Dermatitis, AtopicDermatitisEczema+3 more
Pfizer 41
Early research (Phase 1)Looking for participantsNCT07604324
What this trial is testing

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Novartis Pharmaceuticals 63
Large-scale testing (Phase 3)Enrolling By InvitationNCT07180511
What this trial is testing

A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 460
Not applicableStudy completedNCT05451316
What this trial is testing

Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

Who this might be right for
Atopic Dermatitis
AbbVie 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT06767540
What this trial is testing

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 198
Testing effectiveness (Phase 2)Study completedNCT01639040
What this trial is testing

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 31
Testing effectiveness (Phase 2)UnknownNCT04725136
What this trial is testing

Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT05149313
What this trial is testing

Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

Who this might be right for
Dermatitis, AtopicEczema
Almirall, S.A. 331
Not applicableNot Yet RecruitingNCT07276620
What this trial is testing

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Who this might be right for
Atopic Dermatitis (AD)
Xiangya Hospital of Central South University 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07386743
What this trial is testing

A Phase III Study of GS101 Injection to Dupixent®

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd 572
Not applicableStudy completedNCT05959083
What this trial is testing

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
AbbVie 200
Testing effectiveness (Phase 2)Study completedNCT04922021
What this trial is testing

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
LEO Pharma 58
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Testing effectiveness (Phase 2)Ended earlyNCT05935085
What this trial is testing

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Who this might be right for
Atopic Dermatitis Eczema
AnaptysBio, Inc. 201
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Testing effectiveness (Phase 2)Looking for participantsNCT07441395
What this trial is testing

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more
Corvus Pharmaceuticals, Inc. 200
Early research (Phase 1)Looking for participantsNCT07558668
What this trial is testing

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Sitryx Therapeutics Ltd 149
Early research (Phase 1)Active Not RecruitingNCT07027527
What this trial is testing

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Apogee Therapeutics, Inc. 86
Next Page